Claris Lifesciences shares to delist from BSE on March 22

Promoter Arjun Handa has bought back shares from existing shareholders and now holds 96 per cent in the soon-to-be delisted entity

Claris Lifesciences, Ahmedabad-based pure play injectables player, will be delisted from the BSE, effective March 22, the company said on Monday. The pharma company’s shares will stop trading from March 15.

The company is not listed on the National Stock Exchange. The company had applied for delisting of equity shares on February 26, 2018, it said in a statement. In December, the company had received a letter from promoter Athanas Enterprise to consider delisting of its shares.

Around 95.8 per cent of equity shareholders have opted to sell their shares back at Rs 400 apiece. For the rest, there is